Brain Tumors: From Neuropathology to Molecular Biology

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: 20 August 2024 | Viewed by 276

Special Issue Editors


E-Mail Website
Guest Editor
Department of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy
Interests: neurosurgery; neuro-oncology; neuropathology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy
Interests: neuropathology; neuro-oncology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Molecular Medicine and Medical Biotechnology, School of Medicine, University of Naples “Federico II”, 80131 Naples, Italy
Interests: tumor epigenetics; brain tumors; molecular biology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The classification of brain tumors has recently undergone several changes, primarily due to the identification of new histologic variants and the adoption of novel technologies. Up to several years ago, diagnosis was primarily performed on the basis of histopathological aspect of tumors and several immunohistochemical studies. In the 2016 WHO classification, and even more in the 2021 classification, thanks to the improved understanding of the genetic basis of tumorigenesis, the 2016 and 2021 WHO classifications were able to incorporate molecular findings into brain tumor diagnosis. The use of integrated phenotypic and genotypic parameters, provided by histology and molecular genetics, has provided greater accuracy to diagnosis, patient management, prognosis and treatment response.

Besides, in patients with similar neuropathological findings, the biomolecular studies have defined subgroups with different biomolecular features and different biological behaviors, response to treatment, recurrence rates and survivals. This Issue aims to discuss the improvements in tumor diagnosis and management enabled by biomolecular studies and neuropathology.

Prof. Dr. Francesco Maiuri
Prof. Dr. Marialaura Del Basso De Caro
Prof. Dr. Lorenzo Chiariotti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain tumor pathology
  • neuro-oncology
  • molecular biology
  • immunohistochemistry
  • histopathology

Published Papers

This special issue is now open for submission.
Back to TopTop